Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-14

FDA Approved: FLUCONAZOLE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved Baxter Healthcare Company's supplemental application for fluconazole (ANDA076766). This action confirms authorization of a generic fluconazole prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)